top of page

The AIDS Institute (TAI) has increased its capacity as a major national organization in the fight against viral hepatitis.  In this section you will find summaries of, and links to, various documents such as previous meetings, newsletters and webinar slide sets.  

Hepatitis C Testing Stakeholders Forum

Forum date: February 27, 2015



To advance adoption and implementation of the hepatitis C (HCV) birth cohort testing guidelines at the state level by engaging a cross-section of stakeholders from public health, health systems, government and academia.


The forum was produced by: The AIDS Institute and Florida Department of Health, Hepatitis Prevention Program

Support was provided by the CDC Foundation



Hepatitis in Florida                                                        

Phillip E. Reichert, MPH, Manager, Hepatitis Prevention Program,

Florida Department of Health


Updated Medications for Hepatitis C

Dushyantha Jayaweera, M.D., Professor of Clinical Medicine, Associate Vice Provost for Human Subject Research, University of Miami


HHS Hepatitis Action Plan

Corinna Dan, RN, MPH, Viral Hepatitis Policy Advisor, Office of HIV/AIDS and Infectious Disease Policy, U.S. Department of Health & Human Services


Hepatitis C in the U.S. and the World

Claudia Vellozzi, MD, MPH, Chief, Prevention Branch, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention


Previous E-learning Presentations

Webinar date: October 8, 2014 


Webinar Title:  Federal, State and Local Recommendations for Viral Hepatitis Testing Programs



The National Alliance of State and Territorial AIDS Directors (NASTAD)

Washington, D.C.

  • Chris Taylor, Director, Viral Hepatitis

  • Amanda Bowes, MPH, Associate, Health Care Access and Viral Hepatitis

The AIDS Institute, Tampa, FL

  • Michelle Scavnicky, MS, Director of Education and Capacity Building


To access the PowerPoint slides, click here.


Webinar Date: July 10 2014


Webinar Title: HCV Testing and Coverage --Impact of Healthcare Reform


Webinar Description: Given the complexities of the 2010 Affordable Care Act (ACA), federal Medicare, and state-level Medicaid, reimbursement for HCV screening is being reconsidered on many levels.  This policy webinar addresses: HCV Screening, the USPSTF, Prevention and the ACA, and HCV Screening Coverage by Each Payer.  



Carl Schmid, Executive Director, The AIDS Institute

Washington, D.C.


 To access the corresponding PowerPoint Slide Show, click here

Coming soon!  If you need back issues now please contact

Michelle Scavnicky at

Webinar Date: July 9 2014


Webinar Title:  Deconstructing HCV Treatment


Webinar Description: As treatment for HCV has entered a new period of more FDA-approved therapies (and many more in Phase III clinical trials), TAI's next quarterly Viral Hepatitis webinar will devote the entire 90 minutes to an HCV treatment update.



Philip Styne, M.D., AGAF

(American Gastroenterological Association Fellow)

Medical Director, Digestive Health & Clinical Informatics

Florida Hospital

Orlando, FL


Tracy Swan

Hepatitis/HIV Project Director

Treatment Action Group

New York, NY



The AIDS  Institute (TAI)

Tampa, FL


To access the corresponding PowerPoint Slide Show, click here.

Webinar Date: April 9 2014


Webinar Title: Hepatitis 101


Webinar Description: Those working in the public health fields of HIV, STD, TB, and family health need to be aware of basic elements of viral hepatitis. This 60-minute presentation and discussion will address the types, risk factors, prevention, and treatment of each.  




April Crowley

Health Education Coordinator

Florida Department of Health

Tallahassee, FL




The AIDS Institute (TAI)

Tampa, FL


To access the corresponding PowerPoint Slide Show, click here.




© 2014 by The AIDS Institute

HepFlorida and HepInfoNow are programs

of The AIDS Institute

                             17 Davis Blvd., Suite 403 Tampa, FL 33606 | T 813.258.5929 / F 888.714.7243

1705 DeSales Street NW, Suite 700 Washington, DC 20036 | T 202.835.8373 / F 888.714.7243


bottom of page